Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q24633070)
Watch
English
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
scientific article
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
PubMed
PubMed ID
22658127
retrieved
13 November 2016
title
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
(English)
1 reference
stated in
PubMed
PubMed ID
22658127
retrieved
13 November 2016
main subject
antibody
1 reference
based on heuristic
inferred from title
author
Mario Sznol
series ordinal
30
object named as
Mario Sznol
0 references
Charles G. Drake
series ordinal
15
object named as
Charles G Drake
0 references
F Stephen Hodi
series ordinal
2
object named as
F Stephen Hodi
0 references
Tracee L. McMiller
series ordinal
21
object named as
Tracee L McMiller
0 references
Suzanne L. Topalian
series ordinal
1
object named as
Suzanne L Topalian
0 references
Drew M Pardoll
series ordinal
16
object named as
Drew M Pardoll
0 references
Janis M Taube
series ordinal
20
object named as
Janis M Taube
0 references
author name string
Julie R Brahmer
series ordinal
3
0 references
Scott N Gettinger
series ordinal
4
0 references
David C Smith
series ordinal
5
0 references
David F McDermott
series ordinal
6
0 references
John D Powderly
series ordinal
7
0 references
Richard D Carvajal
series ordinal
8
0 references
Jeffrey A Sosman
series ordinal
9
0 references
Michael B Atkins
series ordinal
10
0 references
Philip D Leming
series ordinal
11
0 references
David R Spigel
series ordinal
12
0 references
Scott J Antonia
series ordinal
13
0 references
Leora Horn
series ordinal
14
0 references
Lieping Chen
series ordinal
17
0 references
William H Sharfman
series ordinal
18
0 references
Robert A Anders
series ordinal
19
0 references
Haiying Xu
series ordinal
22
0 references
Alan J Korman
series ordinal
23
0 references
Maria Jure-Kunkel
series ordinal
24
0 references
Shruti Agrawal
series ordinal
25
0 references
Daniel McDonald
series ordinal
26
0 references
Georgia D Kollia
series ordinal
27
0 references
Ashok Gupta
series ordinal
28
0 references
Jon M Wigginton
series ordinal
29
0 references
language of work or name
English
0 references
publication date
28 June 2012
0 references
published in
The New England Journal of Medicine
0 references
volume
366
0 references
page(s)
2443-54
0 references
issue
26
0 references
on focus list of Wikimedia project
ScienceSource
0 references
cites work
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
7 April 2017
Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
7 April 2017
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
7 April 2017
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
7 April 2017
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
7 April 2017
The consensus coding sequences of human breast and colorectal cancers
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
7 April 2017
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
7 April 2017
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
7 April 2017
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
7 April 2017
Guidelines for the evaluation of immune therapy activity in solid tumors: immune-related response criteria
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
7 April 2017
Enhancement of antitumor immunity by CTLA-4 blockade
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
7 April 2017
Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
7 April 2017
Cancer immunotherapy comes of age
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
7 April 2017
Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
7 April 2017
Toxicity and response criteria of the Eastern Cooperative Oncology Group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
7 April 2017
Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
27 September 2017
Cancer immunotherapy comes of age
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
27 September 2017
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
27 September 2017
Mechanisms of immune evasion by tumors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
27 September 2017
Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
27 September 2017
Optimizing therapy in previously treated non-small cell lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
27 September 2017
Do we need a different set of response assessment criteria for tumor immunotherapy?
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
28 November 2018
Second-line treatment of advanced non-small cell lung cancer
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3544539
retrieved
28 November 2018
Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22658127
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/22658127
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identifiers
DOI
10.1056/NEJMOA1200690
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
344026
OpenCitations bibliographic resource ID
344026
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
344026
PMCID
3544539
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
344026
PubMed ID
22658127
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
344026
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
